Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy
Background: Growth differentiation factor (GDF15) is a superfamily of transforming growth factor-beta which has been suggested to be correlated with various pathological conditions. The current study aimed to investigate the predicted role of circulating GDF15 in diabetic metabolism characteristics...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/11/11/3033 |
| _version_ | 1797492933714247680 |
|---|---|
| author | Shao-Wen Weng Wen-Chieh Chen Feng-Chih Shen Pei-Wen Wang Jung-Fu Chen Chia-Wei Liou |
| author_facet | Shao-Wen Weng Wen-Chieh Chen Feng-Chih Shen Pei-Wen Wang Jung-Fu Chen Chia-Wei Liou |
| author_sort | Shao-Wen Weng |
| collection | DOAJ |
| description | Background: Growth differentiation factor (GDF15) is a superfamily of transforming growth factor-beta which has been suggested to be correlated with various pathological conditions. The current study aimed to investigate the predicted role of circulating GDF15 in diabetic metabolism characteristics and diabetic neuropathy. Methods: 241 diabetic patients and 42 non-diabetic subjects were included to participate in the study. The plasma GDF15 levels were measured using ELISA. Chronic kidney disease and albuminuria were defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) guideline. The nerve conductive study (NCS) was performed with measurement of distal latency, amplitude, nerve conduction velocity (NCV), H-reflex, and F-wave studies. Results: The diabetic group had a significantly higher prevalence of chronic kidney disease and higher plasma GDF15 level. After adjusting for age and BMI, GDF15 was significantly positively correlated with waist circumference (<i>r</i> = 0.332, <i>p</i> = <0.001), hip circumference (<i>r</i> = 0.339, <i>p</i> < 0.001), HbA1c (<i>r</i> = 0.302, <i>p</i> < 0.001), serum creatine (<i>r</i> = 0.146, <i>p</i> = 0.017), urine albumin/creatinine ratio (<i>r</i> = 0.126, <i>p</i> = 0.040), and HOMA-IR (<i>r</i> = 0.166, <i>p</i> = 0.007). As to NCS, GDF15 was significantly correlated with all latency and amplitude of sensory and motor nerves, as well as F-wave and H-reflex latencies. The area under the curve (AUC) in predicting tibial motor nerve neuropathy (MNCV) in all subjects and in the diabetic group for GDF15 was 0.646 (<i>p</i> = 0.001) and 0.610 (<i>p</i> = 0.012), respectively; for HbA1c was 0.639 (<i>p</i> = 0.001) and 0.604 (<i>p</i> = 0.018), respectively. Predicting ulnar sensory nerve neuropathy for GDF15 was 0.639 (<i>p</i> = 0.001) and 0.658 (<i>p</i> = 0.001), respectively; for HbA1c was 0.545 (<i>p</i> = 0.307) and 0.545 (<i>p</i> = 0.335), respectively. Predicting median sensory nerve neuropathy for GDF15 was 0.633 (<i>p</i> = 0.007) and 0.611 (<i>p</i> = 0.032), respectively; for HbA1c was 0.631 (<i>p</i> = 0.008) and 0.607 (<i>p</i> = 0.038), respectively. Predicting CKD for GDF15 was 0.709 (95% CI, 0.648–0.771), <i>p</i> < 0.001) and 0.676 (95% CI, 0.605–0.746), <i>p</i> < 0.001), respectively; for HbA1c was 0.560 (95% CI, 0.493–0.627); <i>p</i> = 0.080) and 0.515 (95% CI, 0.441–0.588); <i>p</i> = 0.697), respectively. Conclusions: We suggest that there is a significant association between the increased serum GDF-15 level and metabolic parameters and diabetic neuropathy. Plasma GDF15 may be an independent predictor of diabetic neuropathy. |
| first_indexed | 2024-03-10T01:12:43Z |
| format | Article |
| id | doaj.art-ec53bde91afa455d8db74df6b6090a70 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-10T01:12:43Z |
| publishDate | 2022-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-ec53bde91afa455d8db74df6b6090a702023-11-23T14:15:40ZengMDPI AGJournal of Clinical Medicine2077-03832022-05-011111303310.3390/jcm11113033Circulating Growth Differentiation Factor 15 Is Associated with Diabetic NeuropathyShao-Wen Weng0Wen-Chieh Chen1Feng-Chih Shen2Pei-Wen Wang3Jung-Fu Chen4Chia-Wei Liou5Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanDepartment of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanDepartment of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanDepartment of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanDepartment of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanCenter for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, TaiwanBackground: Growth differentiation factor (GDF15) is a superfamily of transforming growth factor-beta which has been suggested to be correlated with various pathological conditions. The current study aimed to investigate the predicted role of circulating GDF15 in diabetic metabolism characteristics and diabetic neuropathy. Methods: 241 diabetic patients and 42 non-diabetic subjects were included to participate in the study. The plasma GDF15 levels were measured using ELISA. Chronic kidney disease and albuminuria were defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) guideline. The nerve conductive study (NCS) was performed with measurement of distal latency, amplitude, nerve conduction velocity (NCV), H-reflex, and F-wave studies. Results: The diabetic group had a significantly higher prevalence of chronic kidney disease and higher plasma GDF15 level. After adjusting for age and BMI, GDF15 was significantly positively correlated with waist circumference (<i>r</i> = 0.332, <i>p</i> = <0.001), hip circumference (<i>r</i> = 0.339, <i>p</i> < 0.001), HbA1c (<i>r</i> = 0.302, <i>p</i> < 0.001), serum creatine (<i>r</i> = 0.146, <i>p</i> = 0.017), urine albumin/creatinine ratio (<i>r</i> = 0.126, <i>p</i> = 0.040), and HOMA-IR (<i>r</i> = 0.166, <i>p</i> = 0.007). As to NCS, GDF15 was significantly correlated with all latency and amplitude of sensory and motor nerves, as well as F-wave and H-reflex latencies. The area under the curve (AUC) in predicting tibial motor nerve neuropathy (MNCV) in all subjects and in the diabetic group for GDF15 was 0.646 (<i>p</i> = 0.001) and 0.610 (<i>p</i> = 0.012), respectively; for HbA1c was 0.639 (<i>p</i> = 0.001) and 0.604 (<i>p</i> = 0.018), respectively. Predicting ulnar sensory nerve neuropathy for GDF15 was 0.639 (<i>p</i> = 0.001) and 0.658 (<i>p</i> = 0.001), respectively; for HbA1c was 0.545 (<i>p</i> = 0.307) and 0.545 (<i>p</i> = 0.335), respectively. Predicting median sensory nerve neuropathy for GDF15 was 0.633 (<i>p</i> = 0.007) and 0.611 (<i>p</i> = 0.032), respectively; for HbA1c was 0.631 (<i>p</i> = 0.008) and 0.607 (<i>p</i> = 0.038), respectively. Predicting CKD for GDF15 was 0.709 (95% CI, 0.648–0.771), <i>p</i> < 0.001) and 0.676 (95% CI, 0.605–0.746), <i>p</i> < 0.001), respectively; for HbA1c was 0.560 (95% CI, 0.493–0.627); <i>p</i> = 0.080) and 0.515 (95% CI, 0.441–0.588); <i>p</i> = 0.697), respectively. Conclusions: We suggest that there is a significant association between the increased serum GDF-15 level and metabolic parameters and diabetic neuropathy. Plasma GDF15 may be an independent predictor of diabetic neuropathy.https://www.mdpi.com/2077-0383/11/11/3033growth differentiation factor 15diabetic neuropathynerve conductive studytype 2 DM |
| spellingShingle | Shao-Wen Weng Wen-Chieh Chen Feng-Chih Shen Pei-Wen Wang Jung-Fu Chen Chia-Wei Liou Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy Journal of Clinical Medicine growth differentiation factor 15 diabetic neuropathy nerve conductive study type 2 DM |
| title | Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy |
| title_full | Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy |
| title_fullStr | Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy |
| title_full_unstemmed | Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy |
| title_short | Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy |
| title_sort | circulating growth differentiation factor 15 is associated with diabetic neuropathy |
| topic | growth differentiation factor 15 diabetic neuropathy nerve conductive study type 2 DM |
| url | https://www.mdpi.com/2077-0383/11/11/3033 |
| work_keys_str_mv | AT shaowenweng circulatinggrowthdifferentiationfactor15isassociatedwithdiabeticneuropathy AT wenchiehchen circulatinggrowthdifferentiationfactor15isassociatedwithdiabeticneuropathy AT fengchihshen circulatinggrowthdifferentiationfactor15isassociatedwithdiabeticneuropathy AT peiwenwang circulatinggrowthdifferentiationfactor15isassociatedwithdiabeticneuropathy AT jungfuchen circulatinggrowthdifferentiationfactor15isassociatedwithdiabeticneuropathy AT chiaweiliou circulatinggrowthdifferentiationfactor15isassociatedwithdiabeticneuropathy |